• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动消融试验中的节律监测策略与心律失常复发:一项系统评价

Rhythm-Monitoring Strategy and Arrhythmia Recurrence in Atrial Fibrillation Ablation Trials: A Systematic Review.

作者信息

Unni Rudy R, Prager Ross T, Odabashian Roupen, Zhang Jimmy J, Fat Hing Nicholas Ng, Nery Pablo B, Pi Lebei, Aldawood Wafa, Sadek Mouhannad M, Redpath Calum J, Birnie David H, Alqarawi Wael, Zagzoog Amin, Golian Mehrdad, Klein Andres, Ramirez F Daniel, Green Martin S, Chen Li, Visintini Sarah, Wells George A, Nair Girish M

机构信息

Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Department of Medicine, Western University, London, Ontario, Canada.

出版信息

CJC Open. 2022 Feb 10;4(5):488-496. doi: 10.1016/j.cjco.2022.02.001. eCollection 2022 May.

DOI:10.1016/j.cjco.2022.02.001
PMID:35607484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9123375/
Abstract

BACKGROUND

: The rhythm-monitoring strategy after catheter ablation (CA) for atrial fibrillation (AF) impacts the detection of atrial arrhythmia recurrence and is not well characterized. We performed a systematic review and meta-regression analysis to determine whether the duration and mode of rhythm monitoring after CA affects detection of atrial arrhythmia recurrence.

METHODS

Databases were systematically searched for randomized controlled trials of adult patients undergoing first CA for AF from 2007 to 2021. Duration and strategy of rhythm monitoring were extracted. Meta-regression was used to identify any association between duration of monitoring and detection of atrial arrhythmia recurrence. The primary measure of outcome was single-procedure recurrence of atrial arrhythmia.

RESULTS

The search strategy yielded 57 trial arms from 56 randomized controlled trials comprising 5322 patients: 36 arms of patients with paroxysmal AF (PAF), and 21 arms of patients with persistent AF (PeAF) or both PAF/PeAF. Intermittent monitoring was associated with detection of significantly less atrial arrhythmia recurrence than continuous monitoring in PAF arms (31.2% vs 46.9%,  = 0.001), but not in PeAF/PAF-PeAF combined arms (43.3% vs 63.6%,  = 0.12). No significant relationship was seen between the duration of intermittent rhythm monitoring and atrial arrhythmia recurrence detection in either the PAF ( = 0.93) or PeAF/PAF-PeAF combined arms ( = 0.20).

CONCLUSIONS

Continuous rhythm monitoring detected higher atrial arrhythmia recurrence rates, compared to intermittent rhythm monitoring, in patients with PAF. The duration of intermittent monitoring did not show a statistically significant relationship to the yield of arrhythmia detection, in near identical cohorts of trial subjects undergoing similar interventions, with clinical and research implications.

摘要

背景

心房颤动(AF)导管消融(CA)后的心律监测策略会影响房性心律失常复发的检测,但其特征尚不明确。我们进行了一项系统评价和meta回归分析,以确定CA后心律监测的持续时间和模式是否会影响房性心律失常复发的检测。

方法

系统检索2007年至2021年接受首次AF-CA的成年患者的随机对照试验。提取心律监测的持续时间和策略。采用meta回归分析确定监测持续时间与房性心律失常复发检测之间的关联。主要结局指标是房性心律失常的单次手术复发率。

结果

检索策略从56项随机对照试验中获得了57个试验组,共5322例患者:36个阵发性AF(PAF)患者组,21个持续性AF(PeAF)患者组或PAF/PeAF患者组。在PAF组中,间歇监测与房性心律失常复发检测率显著低于连续监测相关(31.2%对46.9%,P = 0.001),但在PeAF/PAF-PeAF合并组中无此差异(43.3%对63.6%,P = 0.12)。在PAF组(P = 0.93)或PeAF/PAF-PeAF合并组(P = 0.20)中,间歇心律监测的持续时间与房性心律失常复发检测之间均未发现显著关系。

结论

与间歇心律监测相比,连续心律监测在PAF患者中检测到更高的房性心律失常复发率。在接受类似干预的近乎相同的试验对象队列中,间歇监测的持续时间与心律失常检测率之间未显示出统计学上的显著关系,具有临床和研究意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d21/9123375/6303c91ad0e9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d21/9123375/fbeba8b66f65/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d21/9123375/c2be0bb97c91/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d21/9123375/6303c91ad0e9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d21/9123375/fbeba8b66f65/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d21/9123375/c2be0bb97c91/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d21/9123375/6303c91ad0e9/gr3.jpg

相似文献

1
Rhythm-Monitoring Strategy and Arrhythmia Recurrence in Atrial Fibrillation Ablation Trials: A Systematic Review.心房颤动消融试验中的节律监测策略与心律失常复发:一项系统评价
CJC Open. 2022 Feb 10;4(5):488-496. doi: 10.1016/j.cjco.2022.02.001. eCollection 2022 May.
2
Persistent atrial fibrillation over 3 years is associated with higher recurrence after catheter ablation.持续3年以上的持续性心房颤动与导管消融术后较高的复发率相关。
J Cardiovasc Electrophysiol. 2020 Feb;31(2):457-464. doi: 10.1111/jce.14345. Epub 2020 Jan 15.
3
Single-center experience of the FIRM technique to ablate paroxysmal and persistent atrial fibrillation.FIRM 技术消融阵发性和持续性心房颤动的单中心经验。
J Cardiovasc Electrophysiol. 2019 Apr;30(4):493-502. doi: 10.1111/jce.13832. Epub 2019 Jan 8.
4
Electroanatomic characteristics of atrial premature beats triggering atrial fibrillation in patients with persistent versus paroxysmal atrial fibrillation.持续性与阵发性心房颤动患者中触发心房颤动的房性早搏的电解剖特征。
J Cardiovasc Electrophysiol. 2006 Aug;17(8):818-24. doi: 10.1111/j.1540-8167.2006.00503.x.
5
Clinical impact of rotor ablation in atrial fibrillation: a systematic review.转子消融治疗心房颤动的临床影响:系统评价。
Europace. 2018 Jul 1;20(7):1099-1106. doi: 10.1093/europace/eux370.
6
Differences in endothelial dysfunction induced by paroxysmal and persistent atrial fibrillation: Insights from restoration of sinus rhythm by catheter ablation.阵发性和持续性心房颤动引起的血管内皮功能障碍的差异:经导管消融恢复窦性心律的见解。
Int J Cardiol. 2017 Oct 1;244:180-185. doi: 10.1016/j.ijcard.2017.06.038. Epub 2017 Jun 19.
7
Second-Generation Cryoballoon Ablation for Atrial Fibrillation - A Detailed Analysis of the Impact of Left Atrial Volume Index on Clinical Outcome.第二代冷冻球囊消融治疗心房颤动——左心房容积指数对临床结果影响的详细分析。
Circ J. 2018 Dec 25;83(1):84-90. doi: 10.1253/circj.CJ-18-0650. Epub 2018 Nov 14.
8
Biatrial linear ablation in sustained nonpermanent AF: Results of the substrate modification with ablation and antiarrhythmic drugs in nonpermanent atrial fibrillation (SMAN-PAF) trial.持续性非永久性房颤的双房线性消融:消融和抗心律失常药物治疗非永久性房颤(SMAN-PAF)试验中的基质改良结果。
Heart Rhythm. 2016 Feb;13(2):399-406. doi: 10.1016/j.hrthm.2015.10.006. Epub 2015 Oct 9.
9
Predictive value of noninducibility after catheter ablation for paroxysmal and persistent atrial fibrillation.导管消融术后不可诱发性对阵发性和持续性心房颤动的预测价值。
J Arrhythm. 2020 Mar 2;36(3):439-447. doi: 10.1002/joa3.12320. eCollection 2020 Jun.
10
Improvement in renal and endothelial function after catheter ablation in patients with persistent atrial fibrillation.持续性心房颤动患者导管消融术后肾和内皮功能的改善。
J Cardiol. 2020 Dec;76(6):610-617. doi: 10.1016/j.jjcc.2020.07.002. Epub 2020 Jul 15.

引用本文的文献

1
Left Atrial Appendage Thrombus in Low CHA2DS2VASc Score in Persistent Atrial Fibrillation.持续性房颤患者CHA2DS2VASc评分低时的左心耳血栓
Cureus. 2025 Mar 25;17(3):e81160. doi: 10.7759/cureus.81160. eCollection 2025 Mar.
2
Patterns of Postablation Recurrence and Adverse Cardiovascular Outcomes in Patients With Atrial Fibrillation.心房颤动患者消融术后复发模式及不良心血管结局
J Am Heart Assoc. 2025 May 6;14(9):e038832. doi: 10.1161/JAHA.124.038832. Epub 2025 Apr 17.
3
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.

本文引用的文献

1
Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation.冷冻消融或药物治疗用于初始治疗心房颤动。
N Engl J Med. 2021 Jan 28;384(4):305-315. doi: 10.1056/NEJMoa2029980. Epub 2020 Nov 16.
2
Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation.冷冻球囊消融术作为心房颤动的初始治疗。
N Engl J Med. 2021 Jan 28;384(4):316-324. doi: 10.1056/NEJMoa2029554. Epub 2020 Nov 16.
3
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.心房颤动患者的早期节律控制治疗。
2024年欧洲心律协会/心律协会/亚太心律协会/拉丁美洲心律协会关于心房颤动导管消融和外科消融的专家共识声明
J Arrhythm. 2024 Oct 6;40(6):1217-1354. doi: 10.1002/joa3.13082. eCollection 2024 Dec.
4
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.2024 年欧洲心律协会/心律学会/亚太心律学会/拉丁美洲心律学会专家共识声明:关于心房颤动的导管和手术消融。
J Interv Card Electrophysiol. 2024 Aug;67(5):921-1072. doi: 10.1007/s10840-024-01771-5.
5
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.2024 年欧洲心脏节律协会/心律学会/亚太心脏节律学会/拉丁美洲心脏节律学会专家共识声明:导管和手术消融治疗心房颤动。
Europace. 2024 Mar 30;26(4). doi: 10.1093/europace/euae043.
6
Left atrial posterior wall isolation using pulsed-field ablation: procedural characteristics, safety, and mid-term outcomes.使用脉冲场消融进行左心房后壁隔离:手术特点、安全性和中期结果。
J Interv Card Electrophysiol. 2024 Sep;67(6):1359-1364. doi: 10.1007/s10840-023-01728-0. Epub 2024 Jan 5.
7
Efficacy and safety of pulmonary vein isolation with pulsed field ablation vs. novel cryoballoon ablation system for atrial fibrillation.脉冲场消融与新型冷冻球囊消融系统治疗房颤的有效性和安全性比较。
Europace. 2023 Dec 6;25(12). doi: 10.1093/europace/euad329.
8
Accuracy of symptoms and pulse checking for detecting atrial fibrillation following catheter ablation.症状和脉象检查在导管消融后检测心房颤动的准确性。
J Interv Card Electrophysiol. 2024 Apr;67(3):617-623. doi: 10.1007/s10840-023-01643-4. Epub 2023 Sep 12.
N Engl J Med. 2020 Oct 1;383(14):1305-1316. doi: 10.1056/NEJMoa2019422. Epub 2020 Aug 29.
4
Additional Low-Voltage-Area Ablation in Patients With Paroxysmal Atrial Fibrillation: Results of the Randomized Controlled VOLCANO Trial. 阵发性心房颤动患者的附加低电压区消融:随机对照 VOLCANO 试验的结果。
J Am Heart Assoc. 2020 Jul 7;9(13):e015927. doi: 10.1161/JAHA.120.015927. Epub 2020 Jun 24.
5
Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial.连续监测评估的冷冻球囊或射频消融治疗心房颤动:一项随机临床试验。
Circulation. 2019 Nov 26;140(22):1779-1788. doi: 10.1161/CIRCULATIONAHA.119.042622. Epub 2019 Oct 21.
6
Recurrent atrial fibrillation/flutter detection after ablation or cardioversion using the AliveCor KardiaMobile device: iHEART results.使用 AliveCor KardiaMobile 设备进行消融或电复律后复发性心房颤动/扑动的检测:iHEART 研究结果。
J Cardiovasc Electrophysiol. 2019 Nov;30(11):2220-2228. doi: 10.1111/jce.14160. Epub 2019 Sep 25.
7
2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation.2018 年加拿大心血管学会心房颤动管理指南重点更新。
Can J Cardiol. 2018 Nov;34(11):1371-1392. doi: 10.1016/j.cjca.2018.08.026.
8
Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association.房颤负担:超越房颤二元实体概念:美国心脏协会科学声明。
Circulation. 2018 May 15;137(20):e623-e644. doi: 10.1161/CIR.0000000000000568. Epub 2018 Apr 16.
9
Catheter Ablation for Atrial Fibrillation with Heart Failure.心力衰竭合并心房颤动的导管消融治疗。
N Engl J Med. 2018 Feb 1;378(5):417-427. doi: 10.1056/NEJMoa1707855.
10
Safety and long-term effectiveness of paroxysmal atrial fibrillation ablation with a contact force-sensing catheter: real-world experience from a prospective, multicentre observational cohort registry.接触力感知导管消融阵发性心房颤动的安全性和长期疗效:前瞻性多中心观察队列注册研究的真实世界经验。
Europace. 2018 Nov 1;20(FI_3):f410-f418. doi: 10.1093/europace/eux290.